Your fact-checks will appear here
The efficacy of donepezil in treating dementia and its effects on disease progression.
The evidence base for (BM) in age‑related cognitive decline is dominated by small, short trials and systematic reviews that signal possible benefits for attention and some memory measures but remain i...
, based on the materials provided, is a marketed sold for “memory support” and cognitive enhancement, not a prescription drug, and its product pages describe herbal ingredients such as Bacopa rather t...
A systematic review identified five randomized controlled trials (RCTs) that tested in people with Alzheimer’s disease (AD) or mild cognitive impairment () attributable to AD, with wide variation in f...
Existing dementia drugs like donepezil produce small-to-moderate, short‑to‑medium term symptomatic benefits on cognition, global clinical state and daily function, but high‑quality evidence that they ...